Thorazine and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Thorazine (chlorpromazine hydrochloride) and Keppra (levetiracetam). Common drug interactions include neuropathy peripheral among females and balance disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Thorazine and Keppra. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Thorazine?

Thorazine has active ingredients of chlorpromazine hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 3,237 Thorazine users. Check the latest studies of Thorazine.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.



On Jul, 20, 2026

25 people who take Thorazine and Keppra together, and have interactions are studied.

Thorazine and Keppra drug interactions.

What are the common drug interactions of Thorazine and Keppra, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Pancreatitis acute (sudden inflammation of pancreas)
  3. Personality disorder
  4. Pregnancy
  5. Skin bacterial infection
  6. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  7. Suicidal ideation
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Tardive dyskinesia (a disorder that involves involuntary movements)
  10. Thyroid disorder (thyroid diseases)

male:

  1. Balance disorder
  2. Cerebral haemorrhage (bleeding within the brain)
  3. Brain mass
  4. Central nervous system lymphoma (cancer of central nervous system forms in lymph tissue)
  5. Chest pain
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Diarrhoea
  8. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
  9. Dry skin
  10. Dyspepsia (indigestion)

What are the common drug interactions of Thorazine and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Ventricular extrasystoles (premature cardiac contraction)
  2. Blood pressure decreased
  3. Cardiac disorder
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Obesity (having too much body fat)
  7. Petit mal epilepsy (absence seizure)
  8. Suicide attempt
  9. Type 2 diabetes mellitus

30-39:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Nausea (feeling of having an urge to vomit)
  3. Nerve injury
  4. Neuropathy peripheral (surface nerve damage)
  5. Oesophageal obstruction (blockage of oesophagus)
  6. Pancreatitis acute (sudden inflammation of pancreas)
  7. Personality disorder
  8. Pregnancy
  9. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  10. Suicidal ideation

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Balance disorder
  3. Cerebral haemorrhage (bleeding within the brain)
  4. Constipation
  5. Death
  6. Fall
  7. Muscular weakness (muscle weakness)
  8. Nausea (feeling of having an urge to vomit)
  9. Vision blurred
  10. Weight decreased

50-59:

  1. Drug hypersensitivity
  2. Nausea (feeling of having an urge to vomit)
  3. Type 2 diabetes mellitus
  4. Peripheral swelling
  5. Abdominal pain
  6. Back disorder
  7. Blood cholesterol increased
  8. Diabetes mellitus inadequate control
  9. Diarrhoea
  10. Hyperlipidaemia (presence of excess lipids in the blood)

60+:

n/a

What are the existing conditions these people have? *

  1. Migraine (headache): 4 people, 16.00%
  2. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 4 people, 16.00%
  3. Psychotic Disorder: 3 people, 12.00%
  4. Pain: 3 people, 12.00%
  5. Nausea (feeling of having an urge to vomit): 3 people, 12.00%
  6. Insomnia (sleeplessness): 3 people, 12.00%
  7. Depression: 3 people, 12.00%
  8. Stress And Anxiety: 2 people, 8.00%
  9. Sleep Disorder: 2 people, 8.00%
  10. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Thorazine and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Thorazine and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Thorazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thorazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on chlorpromazine hydrochloride and levetiracetam (the active ingredients of Thorazine and Keppra, respectively), and Thorazine and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: